Tin tức & Cập nhật

The use of fremanezumab in children and adolescents with episodic migraine (EM) results in significant reductions in monthly migraine days (MMD) and monthly headache days (MHD), but it appears to be no better than placebo among those with chronic migraine (CM), as shown by outcomes from two randomized, phase III trials presented at AAN 2026.

Some hospitalized children with acute bronchiolitis (AB) and febrile seizures (FB) present with influenza C virus (ICV), which may contribute to more severe clinical presentations, particularly in those with AB, a recent study in Slovenia has found.